Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a fifth-generation (v5) eVLP with enhanced production, transduction, and gene-editing efficiency. This system could pave the way for improved gene delivery vehicles in therapeutic applications.
Revolo advances plans to tackle eosinophilic esophagitis with orphan drug tag – Pharmaceutical Technology
Share this article Eosinophilic esophagitis can be triggered by a food allergy, acid reflux, or seasonal allergies. Credit: CGN089 via Shutterstock. Revolo Biotherapeutics plans to